Last week, the European Commission and the European Medicines Agency (EMA) announced the approval of the first cannabis-based medicine for childhood epilepsy, which is expected to become available in the UK soon.
Figures from GlobalData Retail estimate that the regulated UK market will be worth £1.6bn over 2019, and will generate almost £490.4m for the country. The European market as a whole is due to grow 400% over the next four years, says the Brightfield Group. The cannabis market is growing fast in many countries around the world, especially as cannabis-based medicinal products become more widely available. It is clear that this growth is set to continue in the near future.
Specialists forecast that the UK cannabis market will increase in size over the coming years. Daragh Anglim, Managing Director at the cannabis consultancy Prohibition Partners, told the FT that last year’s legalisation of medicinal cannabis ‘breaks the stigma’ and that he expects the UK market to open up to recreational use within three to five years. Prohibition Partners says the UK cannabis markets could be worth £16.5bn in the next 10 years.
Stefania Barbaglio, Founder and Director of Cassiopeia Services, an Investor Relations company working closely with cannabis projects says: “The cannabis market, specifically medicinal cannabis and its derivatives, are among the hottest trends for investors to watch. The market is still at an early stage, with many opportunities for returns in the medium and long run, and we can expect more exciting news to unfold within this space in the coming months. There is a growing movement to destigmatise the use of cannabis for therapeutic purposes, which is reflected directly in the inflow of companies and investments in this sector in the stock market.”
With the opportunities brewing and more cannabis companies landing in the market, Cassiopeia has selected a few cannabis stocks for investors to take note of and watch out for as the market blooms in the UK and Europe:
Stocks on the London Stock Exchange:
Associated British Foods (LSE: ABF) is a diversified group of businesses, each of which enjoy a high degree of autonomy in the running of their operations. They are grouped into five business segments: Sugar,Agriculture, Retail, Grocery, and Ingredients. ABF has established the capacity to produce cannabis-based products in Norfolk.
Zoetic International (LSE: ZOE), The previous oil and gas company Highland Natural Resources (HNR) has transformed itself into a cannabis business, using its interests in oil and gas to found its new venture. The company has two commercial brands in the US and is now selling CBD tinctures in the UK, aiming to expand its reach to Europe.
“Our immediate priority is to advance the discussions currently underway with potential retail and wholesale partners, purchase manufacturing equipment and expand our outdoor growing, ahead of our intended harvest of our first 10,000 hemp plants by mid-2019,” said CEO and executive Chairman Robert Price.
Integumen PLC (SKIN) is a personal care products company that has established a special division within its team to process and refine CBD to create a product for wound and burn care. The company will use its own labs and leverage on its skincare expertise for the development of the cannabis-based product.
Futura Medical (FUM) is a research and development business specialised in producing transdermal technologies. In September, the company entered into a joint venture agreement with CBDerma Technology Limited to develop a skin-friendly cannabidiol (CBD) formulation.
Cannaray, a British medical cannabis company, raised a £7.8m on a Series A Funding round and aims to raise more than £30m in the coming year in the hope of floating the £100m value on the London Stock Exchange. The company is also set up in Ireland to ensure operations are not disrupted by the uncertain terms of Brexit and to keep access to the European market.
Kanabo Research, an Israel-based medicinal cannabis company is reportedly looking into listing on the London Stock Market. Kanabo has a promised investment of £1.5m from cash shell Spinnaker Opportunities.
Founder Avihu Tamir says: “We have a route for generating cash and revenue almost immediately, but we have potential for much more than that. You’re growing fast or being bought and when you need to grow fast it’s much easier to do it as a public company — the London Stock Exchange gives you that added value.”
Sunrise Resources (SRES) is a natural resources company working to generate profits from the growing cannabis market. Sunrise has signed an agreement to lease a grinding and mineral processing plant near to its CS Pozzolan-Perlite project in Nevada, USA. There is an increased demand for the use of perlite due to the expanding cannabis market in North America.
Stocks on NEX Exchange:
Sativa Group PLC (NEX: SATI) is the UK’s leading quoted medicinal cannabis and wellness cannabidiol (CBD) group, focused on the smart-sourcing of the raw material, advanced extraction, manufacture, testing, distribution, and research & development of medicinal cannabis and CBD products. The company raised £1.1m through the IPO on the capital’s NEX exchange in 2018.
Two UK operating subsidiaries, PhytoVista Laboratories and George Botanicals, are already well established and fully trading in independent CBD testing and CBD wholesale and retail. A new subsidiary, Goodbody Wellness, a CBD retail chain, has been launched in 2019.
World High Life Plc (NEX: LIFE) is a CBD and medicinal cannabis company which started trading on NEX Exchange on September 12. The Company’s investment strategy will focus on markets that are internationally recognised as having well-developed and reputable laws and regulations relating to the research and production of medicinal cannabis, hemp and CBD, as well as therapeutic cannabis derivatives.
“We believe that there are numerous investment opportunities here in Europe that will generate great returns for our shareholders, and we look forward to updating the market with our developments,” said Chairman and CEO David Stadnyk.
AfriAg Global Plc (NEX: AFRI) is a global logistics investment company, focused on the acquisition of direct and indirect interests in projects in logistics sector. In September, the company announced the Opening of Global Center for Medical Cannabis Therapy in Jamaica by Apollon Formularies Jamaica, one of AfriAg investments.
Freyherr International Group (NEX: FRYR) Freyherr International is the UK parent of a mainly Slovenian-based company which grows cannabis and manufactures cannabis-derived concentrates and extracts, focusing its operations within the EU. The company currently grows cannabis in Slovenia and has interests in other production projects. The company has been trading on NEX since August 13.
Block Commodities (NEX: BLCC) is an agritech company aiming to maximise value in African agriculture through the deployment of blockchain technologies. The Company works closely with African farmers to help raise agricultural productivity and to secure better returns for their produce. Building on well-established connections and technology expertise, the Company has expanded its operations into include the medicinal cannabis market with the strategy to produce and process cannabis-based products via licences in Africa, to supply the growing demand in Europe.
Imperial X Plc (NEX: IMPP) is a company seeking investment in the developing market for producing and/or distributing Medicinal Cannabis, its derivatives and/or related products. The company moved into cannabis investments in January 2019, with the accelerating trend towards legalising the use of medicinal cannabis products not only in the UK but in other countries around the world.
Ananda Developments (NEX: ANA) is a company investing in cannabis projects. The Company will seek investments in companies and projects in jurisdictions which have well-developed and reputable laws and regulations for the research and production of Cannabis, and in jurisdictions that are signatories to the United Nation’s conventions on narcotics.
Renowned international stocks with footprints in Europe and the UK:
Aurora Cannabis Inc. (TSX: ACB) (OTC: ACBFF), Headquartered in Canada Edmonton, Alberta and with sales and operations in 14 countries, Aurora is one of the world’s largest and leading cannabis companies. The company announced plans to expand its market to include vapes, concentrates, and edibles. Through a combination of new and enhanced facilities, Aurora intends to produce new, high-quality cannabis-related products across different categories.
“Aurora is the world’s leading producer of high-quality cannabis and we’re ready to introduce high-value product additions to this improved, federally legal market,” said the Company’s CEO Terry Booth.
of marijuana for medical purposes. The company operates in Canada and in Germany, with production facilities in Ontario. The company has subsidiaries in Switzerland and Germany, and has recently obtained a license for growing medical marijuana in Malta. Wayland can also be found in the UK and Italy.
The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) announced an agreement for distribution of cannabis-related products in Greece and Cyprus. Urban Juve, the company in the agreement, plans to register 10 more products for sale in the EU within the next few months.
“This is the first of many territory specific distribution agreements we expect to enter into,” says Penny Green, CEO of Yield Growth. “We are currently in negotiations with distributors for France, Poland, the United Kingdom and Turkey with upcoming meetings set to discuss South America, Germany and Portugal.”
HEXO Corporation (NYSE: HEXO) (TSX: HEXO) is another company leaving its footprint in the European market as the company announces the award of its medical cannabis installation license to establish cultivation, processing and manufacturing facilities, issued by the authorities in Greece.
“This is a major step for HEXO as we continue to execute towards becoming a top three global cannabis company,” said Sebastien St-Louis, HEXO Corp CEO and co-founder. “Receiving licensing in Greece will allow us to bring know-how and brands powered by HEXO to the European market. The new facility will also drive value for current and future Fortune 500 partners by giving them access to licensed infrastructure internationally with the vision of capturing first-mover advantage in the burgeoning European cannabis market.”
FINANCIAL FOX PANEL DISCUSSION: CANNABIS
PR Guru Stefania Barbaglio hosted a panel discussion on FinancialFoxTV with three international experts in the cannabis: American surgeon Dr. Frank D’Ambrosio, global campaigner for cannabis policy reform; Peter Reynolds, president of the UK largest private cannabis policy group CLEAR Cannabis Law reform; and finally Christopher Snowdon, Head of Lifestyle Economics at the Institute of Economic Affairs. All three are in favour of government action on the legalisation of cannabis, for the benefit of society and the economy. #MUSTWATCH
Subscribe to our YouTube channel to stay tuned with our show FinancialFox.
Stay up to date with Cassiopeia news and updates.
Cassiopeia Investor Symposium Autumn Edition, in Central London, Wednsday October 16th. Registration is free and open via Eventbrite: https://www.eventbrite.co.uk/e/cassiopeia-investor-symposium-tickets-73161204131